The store will not work correctly when cookies are disabled.
US9475795, 12
ID: ALA3983167
PubChem CID: 72549099
Max Phase: Preclinical
Molecular Formula: C18H22F3N3O3S
Molecular Weight: 417.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nn(C)c(C)c1S(=O)(=O)N1CCC(Oc2ccc(C(F)(F)F)cc2)CC1
Standard InChI: InChI=1S/C18H22F3N3O3S/c1-12-17(13(2)23(3)22-12)28(25,26)24-10-8-16(9-11-24)27-15-6-4-14(5-7-15)18(19,20)21/h4-7,16H,8-11H2,1-3H3
Standard InChI Key: FJCGDZPNKMJHTF-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
3.1417 1.5281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0377 0.7299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5052 1.0408 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2543 -0.2587 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4477 -0.3849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2499 -1.3728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4917 -2.5482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 -0.7508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5988 -1.5004 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.5984 -2.7004 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6377 -2.1009 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 1.4977 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8990 0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2007 1.4909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4972 0.7364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4920 -0.7636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1903 -1.5091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8939 -0.7546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7891 -1.5185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.8308 -0.9228 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-7.7846 -2.7185 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-8.8260 -2.1226 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
4 6 1 0
6 7 1 0
6 8 2 0
8 2 1 0
8 9 1 0
9 10 2 0
9 11 2 0
9 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 12 1 0
15 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
22 25 1 0
25 26 1 0
25 27 1 0
25 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 417.45 | Molecular Weight (Monoisotopic): 417.1334 | AlogP: 3.29 | #Rotatable Bonds: 4 |
Polar Surface Area: 64.43 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.16 | CX LogP: 2.32 | CX LogD: 2.32 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.77 | Np Likeness Score: -1.76 |
References
1. (2016) Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases, |